Veris Health Expands Oncology Monitoring Platform, Plans Implantable Sensor By 2026

 
• By Marion Webb
  
Veris ICM
External devices plus patient self-reporting are standard, but Veris’s implantable monitor, once cleared by the FDA, could offer more continuous, objective data. (image courtesy of Veris)

More from Strategy

More from Business